All India Institute of Medical Sciences, New Delhi
AIIMS New Delhi is India's flagship public medical institute; its Rotary Cancer Hospital and the National Cancer Institute campus at Jhajjar anchor government cancer research, and its investigators lead Indian studies in paediatric oncology, gallbladder cancer, PSMA radioligand therapy and low-cost CAR-T.
Overview
AIIMS New Delhi was created by an Act of Parliament in 1956 as India's flagship medical institute and hospital. Cancer care is concentrated in the Dr B.R. Ambedkar Institute Rotary Cancer Hospital, opened in 1983, and in the National Cancer Institute at Jhajjar, Haryana, a large AIIMS-run cancer campus commissioned from 2019 with proton therapy planned and a national biobank and screening research mandate. AIIMS investigators lead Indian studies in paediatric oncology, gallbladder cancer (unusually common in northern India), oral and cervical cancer screening, radiation oncology and nuclear medicine (PSMA and FAPI PET, radioligand therapy), and haematology including low-cost CAR-T development with IIT Bombay partners. It sets national training standards and publishes the largest volume of oncology research of any Indian public institution.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to All India Institute of Medical Sciences, including child institutions. 634 works · 4,116 citations · 69% open access · 7% clinical trials · 5% reviews.
- Ajay Gogia49 works
- Atul Batra28 works
- Rachna Kapoor Seth24 works
- Jagdish Prasad Meena23 works
- Sameer Rastogi22 works
- Chandra Prakash Prasad18 works
- Sameer Bakhshi16 works
- Prabhat Singh Malik16 works
- S. V. S. Deo16 works
- Shuvadeep Ganguly15 works
- Rotary Cancer Hospital
- National Cancer Institute Jhajjar
- Nuclear medicine and theranostics
- Paediatric oncology
- Gallbladder cancer
Similar pages
not linked directly; found by shared links- TrialPOP-RT
Shares PSMA PET, Prostate cancer.
- InstitutionRadboudumc Centre for Oncology
Shares PSMA PET, Prostate cancer.
- PersonRahul Aggarwal
Shares PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.
- InstitutionUniversity Hospital Düsseldorf / CIO Düsseldorf
Shares FAPI PET, PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.
- InstitutionCuranosticum Wiesbaden-Frankfurt
- PersonThomas A. Hope
Shares PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.
- PersonJohannes Czernin
Shares PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.
- PersonEbrahim S. Delpassand